Bayer Statement on Release of the ATSDR Draft Toxicological Profile for Glyphosate
Bayer released the following statement regarding the release of a draft toxicological profile for glyphosate by the Agency for Toxic Substances and and Disease Registry (ATSDR).
“We welcome this scientific review of glyphosate, the active ingredient in many of our Roundup-branded products. It is important to recognize that this is a review of the existing scientific literature on glyphosate; it does not contain new or original science. Our scientists are reviewing the report, and we plan to provide comments during the 90-day public comment period.
“Significantly, the report contains a summary of eight international agency assessments of carcinogenicity (table 2-13, page 94) that, with the one exception of IARC, conclude that glyphosate is not carcinogenic. The table reinforces the basis for Bayer’s confidence in the safety of glyphosate, as regulators around the world who have reviewed the extensive science on glyphosate continue to conclude that it is safe for use and is not carcinogenic. And, IARC remains an outlier. The ATSDR profile also notes that “most studies found no association between exposure to glyphosate-based products and risk of cancer.”